Ondansetron HCL 4 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FBAFR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $47,206
Award facts
- Contract value 100% obligated
- $47,205.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $47,205.57 delivery order to Amerisourcebergen Drug Corp on May 21, 2026, for Ondansetron HCL 4 30S with an ultimate completion date of May 22, 2026.
Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and operates as a pharmaceutical distributor and medical supplier serving Defense Health Agency and military healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FBAFR?
SPE2DR26FBAFR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 21, 2026.
How much is contract SPE2DR26FBAFR worth?
The government has obligated $47,206 on SPE2DR26FBAFR.
Is contract SPE2DR26FBAFR an order under another contract?
Yes. SPE2DR26FBAFR is a delivery order under SPE2DR25D6028, an indefinite delivery contract.
Was contract SPE2DR26FBAFR competed?
The extent of competition for SPE2DR26FBAFR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award